KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBIT Margin: 2009-2024

Historic EBIT Margin for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to -1.49%.

  • Dynavax Technologies' EBIT Margin rose 992.00% to 22.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16%, marking a year-over-year increase of 737.00%. This contributed to the annual value of -1.49% for FY2024, which is 1445.00% up from last year.
  • Latest data reveals that Dynavax Technologies reported EBIT Margin of -1.49% as of FY2024, which was up 90.67% from -15.94% recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' EBIT Margin registered a high of 39.23% during FY2022, and its lowest value of -146.87% during FY2020.
  • Moreover, its 3-year median value for EBIT Margin was -1.49% (2024), whereas its average is 7.27%.
  • Per our database at Business Quant, Dynavax Technologies' EBIT Margin surged by 23,600bps in 2020 and then tumbled by 5,517bps in 2023.
  • Dynavax Technologies' EBIT Margin (Yearly) stood at -146.87% in 2020, then surged by 17,748bps to 30.60% in 2021, then skyrocketed by 863bps to 39.23% in 2022, then slumped by 5,517bps to -15.94% in 2023, then soared by 1,445bps to -1.49% in 2024.